Description
ORDERING OFFICER DELEGATION EXPRESS REPORT - 1 ORDER DRUGS
Base award description: ORDERING OFFICER EXPRESS REPORT - 7 ORDERS FOR NCO 18 - DRUGS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-07-31+$21,422= $21,422
- Mod 12013-08-01+$3,060= $24,482
- Mod 22013-09-01+$3,060= $27,543
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-07-31 | +$21,422 | $21,422 | ORDERING OFFICER EXPRESS REPORT - 7 ORDERS FOR NCO 18 - DRUGS |
| Mod 1· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLI | 2013-08-01 | +$3,060 | $24,482 | ORDERING OFFICER DELEGATION REPORT - 1 ORDER - 8/1/13 - 8/31/13 649-3D0036 |
| Mod 2· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLI | 2013-09-01 | +$3,060 | $27,543 | ORDERING OFFICER DELEGATION EXPRESS REPORT - 1 ORDER DRUGS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI MHBQULRMEEJ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79725D0032 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36E79725D0030 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36C77024P0393 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $243,101 | FY2024 |
| 36F79724D0130 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C25024F0047 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $215,205 | FY2024 |
| 36E79723A0023 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
Other recipients under 6505 from 258-NETWORK CONTRACT OFFICE 18 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25816P1062 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $18,604 | FY2016 |
| VA25816E1145 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $10,361,853 | FY2016 |
| VA25816P0866 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $27,127 | FY2016 |
| VA25816J0835 | MDD US OPERATIONS, LLC | 258-NETWORK CONTRACT OFFICE 18 | $3,524 | FY2016 |
| VA25816E1024 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $9,829,900 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA258FY13QTR4PFIZERINCORPORATAED_3600_VA797BP0412_3600 · retrieved 2026-09-26.